Multiple Myeloma & MRD
What is Multiple Myeloma?
MM is
a blood cancer
characterized by the clonal expansion of plasma cells in the
bone marrow
. Myeloma is rare, accounting for 1% of all cancers.
MM diagnosis and monitoring
Multiple myeloma diagnosis and monitoring are based on
clinical symptoms
and
a variety of laboratory tests
. M-protein detection and quantification are integral parts of diagnosis and monitoring of MM.
What is MRD ?
MRD stands for
Minimal Residual Disease
. It refers to the
very small number of myeloma cells that are present in the bone marrow after treatment
. These remaining cells often cannot be detected through traditional tests of treatment response. However, they have the
potential to multiply and cause relapse
.
M-inSight®
Resources
About us
Corgenix
Contracted Services to Improve Patient Outcomes
Sebia
The new language of life
Contact us
How to order?
Order M-inSight®
Multiple Myeloma & MRD
M-inSight®
Resources
About us
Contact us
How to order?
Order M-inSight®
Back
What is Multiple Myeloma?
MM diagnosis and monitoring
What is MRD ?
Back
Corgenix
Sebia
Back
Events
03/19/2024
European Myeloma Network Meeting - EMN 2024
European Myeloma Network Meeting - EMN 2024 Torino, Italy
Sebia booth: #9
Come & Meet us on the Sebia booth #9
Location: Torino, Italy
Learn more
EMN Website
More articles
View all articles
Events
11/22/2023
American Society of Hematology - ASH 2023
Events
06/29/2023
International Myeloma Society 2023
